IT8820145A0 - Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. - Google Patents

Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Info

Publication number
IT8820145A0
IT8820145A0 IT8820145A IT2014588A IT8820145A0 IT 8820145 A0 IT8820145 A0 IT 8820145A0 IT 8820145 A IT8820145 A IT 8820145A IT 2014588 A IT2014588 A IT 2014588A IT 8820145 A0 IT8820145 A0 IT 8820145A0
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical composition
controlled release
release pharmaceutical
Prior art date
Application number
IT8820145A
Other languages
English (en)
Other versions
IT1216570B (it
Inventor
Maria Lucia Lovrecich
Original Assignee
Vectorpharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma Int filed Critical Vectorpharma Int
Priority to IT8820145A priority Critical patent/IT1216570B/it
Publication of IT8820145A0 publication Critical patent/IT8820145A0/it
Priority to US07/276,489 priority patent/US5008114A/en
Priority to DE8888120153T priority patent/DE3872382T2/de
Priority to AT88120153T priority patent/ATE77547T1/de
Priority to EP88120153A priority patent/EP0336014B1/en
Priority to ES88120153T priority patent/ES2042700T3/es
Application granted granted Critical
Publication of IT1216570B publication Critical patent/IT1216570B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IT8820145A 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. IT1216570B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
US07/276,489 US5008114A (en) 1988-04-08 1988-11-28 Pharmaceutical compositions with controlled release, and a method for their preparation
DE8888120153T DE3872382T2 (de) 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
AT88120153T ATE77547T1 (de) 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
EP88120153A EP0336014B1 (en) 1988-04-08 1988-12-02 Pharmaceutical compositions with controlled release, and a method for their preparation
ES88120153T ES2042700T3 (es) 1988-04-08 1988-12-02 Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Publications (2)

Publication Number Publication Date
IT8820145A0 true IT8820145A0 (it) 1988-04-08
IT1216570B IT1216570B (it) 1990-03-08

Family

ID=11164167

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Country Status (6)

Country Link
US (1) US5008114A (it)
EP (1) EP0336014B1 (it)
AT (1) ATE77547T1 (it)
DE (1) DE3872382T2 (it)
ES (1) ES2042700T3 (it)
IT (1) IT1216570B (it)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290570A (en) * 1989-05-30 1994-03-01 Purepac, Inc. Lotions containing liquid-loaded powder
FR2694701B1 (fr) * 1990-04-18 1996-01-19 Biagianti Irene Application des zeolithes naturelles a l'homme et a l'environnement.
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
US5409903A (en) * 1992-02-18 1995-04-25 Urecap Corporation Method and compositions for the treatment of H. pylori and dermatitis
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
AU4932493A (en) * 1992-09-25 1994-04-26 Dynagen, Inc. An immunobooster for delayed release of immunogen
EP0669128B1 (en) * 1992-11-17 2000-01-05 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
CA2151260A1 (en) * 1993-02-23 1994-09-01 Warner-Lambert Company A process for the preparation of substantially alcohol free pharmaceutical compositions
ATE288270T1 (de) * 1993-11-19 2005-02-15 Janssen Pharmaceutica Nv Mikroverkapselte 1,2-benzazole
DE4416001C2 (de) * 1994-05-06 1997-12-11 Feinchemie Gmbh Sebnitz Komposite zur steuerbaren Wirkstoff-Freisetzung
AU4990696A (en) * 1995-02-24 1996-09-11 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
NZ332968A (en) * 1996-05-29 2000-08-25 Bioxid Oy A controllably dissolvable silica-xerogel prepared via sol-gel
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
AU764663C (en) * 1999-02-22 2005-02-03 Bayer Innovation Gmbh Biodegradable ceramic fibres from silica sols
GB9904485D0 (en) * 1999-02-27 1999-04-21 Procter & Gamble Method for protecting and/or controlled release of active ingredient
US6833192B1 (en) 1999-06-10 2004-12-21 Max-Planck Gesellschaft Zur Forderrung Der Wissenschaften E.V. Encapsulation of crystals via multilayer coatings
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
KR100759635B1 (ko) * 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
DE60320940D1 (de) * 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
JP2007501218A (ja) * 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
ITMI20071930A1 (it) * 2007-10-05 2009-04-06 Sasol Italy S P A Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso
DK2403482T3 (en) 2009-03-04 2018-03-05 Emplicure Ab ABUSE RESISTANT FORMULATION
WO2010128300A1 (en) 2009-05-08 2010-11-11 Aduro Materials Ab Composition for sustained drug delivery comprising geopolymeric binder
NZ608598A (en) 2010-09-07 2015-03-27 Orexo Ab A transdermal drug administration device
WO2013096596A1 (en) * 2011-12-20 2013-06-27 Latham Keith R Sustained drug release and improved product stability using non-covalent particle coating methods
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
JP2017511331A (ja) * 2014-03-31 2017-04-20 ノバルティス ファーマ アーゲー 薬学的活性種を含む化合物を含有する多孔質材料
GB201502073D0 (en) 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd HDEG technology
JP7672268B2 (ja) * 2020-04-22 2025-05-07 沢井製薬株式会社 コハク酸ソリフェナシン含有コーティング粒子及びそれを含む口腔内崩壊錠

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923969A (en) * 1973-06-12 1975-12-02 Battelle Institut E V Carrier system for a drug with sustained release
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
GB8606468D0 (en) * 1986-03-15 1986-04-23 Sds Biotech Uk Ltd Therapeutic compositions
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
JPS6327502A (ja) * 1986-07-22 1988-02-05 Agency Of Ind Science & Technol シクロデキストリン−シリカ複合体及びその製造方法

Also Published As

Publication number Publication date
DE3872382T2 (de) 1992-12-10
EP0336014A1 (en) 1989-10-11
DE3872382D1 (de) 1992-07-30
IT1216570B (it) 1990-03-08
ES2042700T3 (es) 1993-12-16
EP0336014B1 (en) 1992-06-24
ATE77547T1 (de) 1992-07-15
US5008114A (en) 1991-04-16

Similar Documents

Publication Publication Date Title
DE68901417D1 (de) Pharmazeutische zusammensetzung.
GB2218905B (en) Controlled release pharmaceutical
NO903001D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater med forlenget frigivelse.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK489189A (da) Farmaceutisk praeparat
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
IT1229562B (it) Composizioni farmaceutiche antivirali ed immunostimolanti e procedimento per la loro preparazione.
IT8919279A0 (it) Composizioni farmaceutiche contenenti un estratto vegetale e procedimento per la loro preparazione.
FI903589A7 (fi) Lääkkeitä, jotka pohjautuvat 4,1,2-1H-bentsoksadiatsiinin johdannaisiin, uusia johdannaisia ja menetelmiä niiden valmistamiseksi
GB8917687D0 (en) Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
DK603988D0 (da) Farmaceutisk praeparat
DK496889A (da) Peptidholdigt farmaceutisk praeparat
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
DK336489A (da) Farmaceutisk praeparat
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
GB8801863D0 (en) Pharmaceutical formulations with controlled drug release
BR9006025A (pt) Preparacao farmaceutica
ATA133288A (de) Pharmazeutische zusammensetzung
DE58905160D1 (de) Pharmazeutische zubereitung.
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
GB8911073D0 (en) New benzofuran derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same
ZA8999B (en) New indolylpieridine compounds,processes for the preparation thereof and pharmaceutical composition comprising the same
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
DK638889D0 (da) Farmaceutisk kombinationspraeparat